Francesco Pepe
0000-0002-2803-9586
74 papers found
Refreshing results…
Predictive molecular pathology in the time of COVID-19
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel
Predictive biomarkers for molecular pathology in lung cancer
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer
[Liquid biopsy as indication of tumour progression in lung cancer: a potential intervention in tertiary prevention].
Understanding EGFR heterogeneity in lung cancer
Next generation sequencing identifies novel potential actionable mutations for grade i meningioma treatment
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas
EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing
Consistency and reproducibility of next‐generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens
Microfluidic chip technology applied to fine‐needle aspiration cytology samples for IGH clonality assessment
<b><i>BRAF</i></b> Mutations in Lung Cancer
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients
Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models
Missing publications? Search for publications with a matching author name.